Tradestie Institutional Equity Comparison Engine

ARIA vs INCY โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

INCY Overall Edge

INCY Captures Institutional Edge (4โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Incyte Genomics Inc (INCY) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ARIA trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus INCY at 13.9x Forward P/E and 32.2% operating margin (+14.0% YoY). In options structure, ARIA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against INCY sits in CONSOLIDATION (73rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner INCY
ARIA N/M vs INCY 13.9x Fwd P/E
Growth & Margin Winner INCY
Op Margin N/A vs 32.2% ยท YoY N/A vs +14.0%
Momentum & Technical Winner INCY
1Y -17.0% vs +14.1% ยท 52W Pos 0% vs 72%
Options & Structure Winner INCY
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (73rd %ile IV)
ARIA US Equity
ARIA
Institutional Equity
$21.03
-3.52% 1D
Market Cap N/A
1M Return -11.55%
1Y Return -16.97%
Forward P/E N/M
Unified AI Score
47.7 / 100 HOLD
Tech 50.0 Fund 52.0 Flow 50.0 Mom 60.0
INCY NASDAQ
Incyte Genomics Inc
Services-Commercial Physical & Biological Research
$120.27
-0.58% 1D
Market Cap $24.7B
1M Return +6.37%
1Y Return +14.1%
Forward P/E 13.9x
Unified AI Score
58.9 / 100 HOLD
Tech 45.0 Fund 56.0 Flow 68.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ARIA -16.97% INCY +14.1% Spread: +15.92 pp (INCY Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ARIA TTM Op. Margin: N/A INCY TTM Op. Margin: 32.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ARIA vs INCY. Trailing 12-month operating profitability (ARIA N/A vs INCY 32.2%) and valuation multiples (ARIA N/M vs INCY 13.9x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ARIA (0) vs INCY (10)
Institutional Metric ARIA INCY Criterion Row Winner
Market Capitalization Scale N/A $24.7B Larger Scale INCY
Trailing P/E Ratio Valuation N/M 61.7x Lower Multiple INCY
Forward P/E Ratio Valuation N/M 13.9x Lower Multiple INCY
Revenue Growth (YoY) Growth N/A +14.0% Higher Growth INCY
Operating Margin (TTM) Profitability N/A 32.2% Higher Margin INCY
Net Profit Margin Profitability N/A 6.7% Higher Margin INCY
Return on Equity (ROE) Capital Efficiency N/A 7.8% Higher ROE INCY
52-Week Range Position Momentum 0% ($21โ€“$27) 72% ($89โ€“$133) Stronger Trend INCY
Beta / 30D Volatility Risk Regime 1.92ฮฒ ยท 43% Vol 0.30ฮฒ ยท 35% Vol Lower Realized Risk INCY
Unified Institutional Score Composite Signal 47.7 / 100 (HOLD) 58.9 / 100 (HOLD) Higher Composite INCY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ARIA vs INCY Buy Guide
ARIA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ARIA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
INCY CONSOLIDATION
78d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 73rd %ile
IV Regime Elevated (60thโ€“80th %ile)
Live INCY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ARIA nor INCY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.